X @Bloomberg

Investment Strategy - Denmark's largest pension fund has increased its investment in Novo Nordisk [1] - The fund anticipates Novo Nordisk will outperform competitors outside the US market [1] Company Performance & Challenges - Novo Nordisk has faced challenges in the US market [1] - These challenges have resulted in two profit warnings for Novo Nordisk [1] Industry Focus - The investment is driven by the potential of Novo Nordisk's obesity drug [1]